Xenon Pharmaceuticals Inc. ($XENE)
Filing Information
| Accession Number | 0001193125-26-009238 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 9, 2026 |
| Document Date | Jan 9, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
120,000
Total Value
$0.00
P&L
+inf% (+$6,592,800.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Share Option (Right to Buy) | Derivative | Jan 9, 2026 | Grant/Award | 100,000 | $0.00 | $0.00 | 100,000 | Direct | โ | View Details | |
Chief Medical Officer | Restricted Share Units | Derivative | Jan 9, 2026 | Grant/Award | 20,000 | $0.00 | $0.00 | 20,000 | Direct | โ | View Details |